These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 16026564

  • 1. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation.
    Mikkonen K, Knip M, Pakarinen AJ, Lanning P, Isojärvi JI, Vainionpää LK.
    Epilepsia; 2005 Jul; 46(7):1114-20. PubMed ID: 16026564
    [Abstract] [Full Text] [Related]

  • 2. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
    El-Khayat HA, Abd El-Basset FZ, Tomoum HY, Tohamy SM, Zaky AA, Mohamed MS, Hakky SM, El Barbary NS, Nassef NM.
    Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076
    [Abstract] [Full Text] [Related]

  • 3. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy.
    Rättyä J, Vainionpää L, Knip M, Lanning P, Isojärvi JI.
    Pediatrics; 1999 Mar; 103(3):588-93. PubMed ID: 10049961
    [Abstract] [Full Text] [Related]

  • 4. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy.
    Geda G, Caksen H, Içağasioğlu D.
    Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250
    [Abstract] [Full Text] [Related]

  • 5. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication.
    Vainionpää LK, Mikkonen K, Rättyä J, Knip M, Pakarinen AJ, Myllylä VV, Isojärvi JI.
    Epilepsia; 2004 Mar; 45(3):197-203. PubMed ID: 15009219
    [Abstract] [Full Text] [Related]

  • 6. Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy.
    Mikkonen K, Tapanainen P, Pakarinen AJ, Päivänsalo M, Isojärvi JI, Vainionpää LK.
    Epilepsia; 2004 Jul; 45(7):769-76. PubMed ID: 15230700
    [Abstract] [Full Text] [Related]

  • 7. Endocrine effects of valproate in adolescent girls with epilepsy.
    de Vries L, Karasik A, Landau Z, Phillip M, Kiviti S, Goldberg-Stern H.
    Epilepsia; 2007 Mar; 48(3):470-7. PubMed ID: 17326798
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V, Pakarinen A, Knip M, Isojärvi J.
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [Abstract] [Full Text] [Related]

  • 10. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
    Voudris KA, Attilakos A, Katsarou E, Drakatos A, Dimou S, Mastroyianni S, Skardoutsou A, Prassouli A, Garoufi A.
    Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G, Abraham I, Haslinger M, Trinka E, Seppi K, Unterberger I, Alge A, Windisch J, Lechleitner M, Bauer G.
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [Abstract] [Full Text] [Related]

  • 12. Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.
    Grosso S, Mostardini R, Piccini B, Balestri P.
    Ann Pharmacother; 2009 Jan; 43(1):45-50. PubMed ID: 19066323
    [Abstract] [Full Text] [Related]

  • 13. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
    Uçar B, Kiliç Z, Dinleyici EC, Colak O, Güneş E.
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
    [Abstract] [Full Text] [Related]

  • 14. Serum lipids, body mass index and waist circumference during pubertal development in Spanish adolescents: the AVENA Study.
    Ruiz JR, Ortega FB, Tresaco B, Wärnberg J, Mesa JL, González-Gross M, Moreno LA, Marcos A, Gutiérrez A, Castillo MJ, AVENA Study Group.
    Horm Metab Res; 2006 Dec; 38(12):832-7. PubMed ID: 17163360
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M, Haberlandt E, Scholl-Bürgi S, Karall D, Schoenherr E, Tatarczyk T, Engl J, Laimer M, Luef G, Ebenbichler CF.
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country.
    Phabphal K, Limapichat K, Sathirapanya P, Setthawatcharawanich S, Leelawattana R, Thammakumpee N, Thamaprasit A, Geater A.
    Epileptic Disord; 2008 Sep; 10(3):213-8. PubMed ID: 18782690
    [Abstract] [Full Text] [Related]

  • 20. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
    Hiransuthikul N, Hiransuthikul P, Kanasook Y.
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.